Tech Company Financing Transactions
Alpha-9 Theranostics Funding Round
Alpha-9 Theranostics, operating out of Boston, secured $75 million in investment from Nextech Invest, BVF Partners and Frazier Healthcare Partners.
Transaction Overview
Company Name
Announced On
12/14/2022
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors
Nextech Invest (Lead Investor) (Melissa McCracken)
Proceeds Purpose
The Series B funding will support advancement of the company's five programs into the clinic over the next two years while expanding its early-stage programs.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
131 Dartmouth St, 3rd Fl
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Undisclosed
Website
Email Address
Overview
Alpha-9 Theranostics is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment of people living with cancer. Applying proprietary technologies and deep-foundational expertise, Alpha-9 is on the forefront of engineering bespoke radiopharmaceuticals that are optimized to selectively deliver radiation to tumor sites while minimizing off-target effects. Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. Alpha-9 was founded by researchers from the University of British Columbia and BC Cancer, with the goal of improving the lives of patients affected by metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Hirsch
Chief Financial Officer
Matthias Jaffe
Chief Operating Officer
Alison Fleming
Browse more venture capital transactions:
Prev: 12/14/2022: Rithum venture capital transaction
Next: 12/14/2022: EnviroSpark venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC transactions reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs